Statistics
Publications
17
Citations
946
H-Index
14
Active since
2017
Ruocong Zhao is an author at Guangzhou Institutes of Biomedicine and Health specializing in cancer immunology, immunology, and immunotherapy.
Publications per year
2017–2025
17
17
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
Jiang Lv, Ruocong Zhao, Di Wu et al. · Journal of Hematology & Oncology · 2019 · 140 citations · Full text
Life Sciences, Immunology, Oncology +17
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
Xinru Wei, Yunxin Lai, Jin Li et al. · OncoImmunology · 2017 · 139 citations · Full text
Medicine, Immunology, Oncology +17
Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells
Yunxin Lai, Jianyu Weng, Xuefeng Wei et al. · Leukemia · 2017 · 107 citations
Life Sciences, Immunology, Oncology +12
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Le Qin, Ruocong Zhao, Dongmei Chen et al. · Biomarker Research · 2020 · 66 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 17